{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:55:12Z","timestamp":1774295712657,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-026-00544-5","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:34:28Z","timestamp":1774247668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic testing for hereditary breast and ovarian cancer in the Murcian population using a comprehensive NGS panel"],"prefix":"10.1007","volume":"25","author":[{"given":"Y.","family":"Mestre Terkemani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rosado Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda Aliaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Sarabia Meseguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mar\u00edn Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Mac\u00edas Cerrolaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"S\u00e1nchez Henarejos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Garc\u00eda Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zafra Poves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Alvarez Abril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Garc\u00eda Torralba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. B.","family":"L\u00f3pez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Moya Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Moreno Locubiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"S\u00e1nchez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A.","family":"Quir\u00f3s Figell\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Cer\u00f3n Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Exp\u00f3sito Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ant\u00f3n Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mart\u00ednez Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ayala de la Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Alonso Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Noguera Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ruiz Espejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"544_CR1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s12282-020-01148-2","volume":"28","author":"R Yoshida","year":"2021","unstructured":"Yoshida R (2021) Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer 28:1167\u20131180. https:\/\/doi.org\/10.1007\/s12282-020-01148-2","journal-title":"Breast Cancer"},{"key":"544_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12094-019-02262-0","volume":"22","author":"S Gonz\u00e1lez-Santiago","year":"2020","unstructured":"Gonz\u00e1lez-Santiago S, Ram\u00f3n y Cajal T, Aguirre E, Al\u00e9s-Mart\u00ednez JE, Andr\u00e9s R, Balma\u00f1a J, Gra\u00f1a B, Herrero A, Llort G, Gonz\u00e1lez-del-Alba, The SEOM Hereditary Cancer Working Group (2020) SEOM clinical guidelines in hereditary breast and ovarian cancer (2019). Clin Transl Oncol 22:193\u2013200. https:\/\/doi.org\/10.1007\/s12094-019-02262-0","journal-title":"Clin Transl Oncol"},{"key":"544_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","volume":"17","author":"G Llort","year":"2015","unstructured":"Llort G, Chirivella I, Morales R, Serrano R, Sanchez AB, Teul\u00e9 A, Lastra E, Brunet J, Balma\u00f1a J, Gra\u00f1a B, SEOM Hereditary Cancer Working Group (2015) SEOM clinical guidelines in Hereditary Breast and ovarian cancer. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 17:956\u2013961. https:\/\/doi.org\/10.1007\/s12094-015-1435-3","journal-title":"Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"key":"544_CR4","unstructured":"National Cancer Institute (NCI), Genetics of Breast and Gynecologic Cancers (PDQ\u00ae) (2026) https:\/\/www.cancer.gov\/types\/breast\/hp\/breast-ovarian-genetics-pdq Accessed 04 Jan 2026"},{"key":"544_CR5","unstructured":"National Comprehensive Cancer Network (NCCN), Guidelines Navigator NCCN (2026) https:\/\/www.nccn.org\/guidelines\/nccn-guidelines-navigator. Accessed 04 Jan 2026"},{"key":"544_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41431-022-01091-0","volume":"30","author":"ZC Deans","year":"2022","unstructured":"Deans ZC, Ahn JW, Carreira IM, Dequeker E, Henderson M, Lovrecic L, \u00d5unap K, Tabiner M, Treacy R, van Asperen CJ (2022) Recommendations for reporting results of diagnostic genomic testing. Eur J Hum Genet 30:1011\u20131016. https:\/\/doi.org\/10.1038\/s41431-022-01091-0","journal-title":"Eur J Hum Genet"},{"key":"544_CR7","unstructured":"VarSome THG, Community (2026) https:\/\/varsome.com\/. Accessed 04 Jan 2026"},{"key":"544_CR8","unstructured":"Genoox (2026) Franklin AI-assisted variant interpretation platform. https:\/\/franklin.genoox.com\/clinical-db\/home. Accessed 04 Jan 2026"},{"key":"544_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41431-021-01013-6","volume":"30","author":"A McGuigan","year":"2022","unstructured":"McGuigan A, Whitworth J, Andreou A, Hearn T, Genomics England Research Consortium, Tischkowitz M, Maher ER (2022) Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update. Eur J Hum Genet EJHG 30:265\u2013270. https:\/\/doi.org\/10.1038\/s41431-021-01013-6","journal-title":"Eur J Hum Genet EJHG"},{"key":"544_CR10","unstructured":"Ministerio de, Sanidad (2024) Cat\u00e1logo Com\u00fan de Pruebas Gen\u00e9ticas y Gen\u00f3micas del SNS. https:\/\/cgen.sanidad.gob.es\/. Accessed 04 Jan 2026"},{"key":"544_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux A-F, Smith T, Antonarakis SE, Taschner PEM (2016) HGVS recommendations for the description of sequence variants: 2016 Update. Hum Mutat 37:564\u2013569. https:\/\/doi.org\/10.1002\/humu.22981","journal-title":"Hum Mutat"},{"key":"544_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"544_CR13","unstructured":"ClinGen CG, Resource (2026) https:\/\/clinicalgenome.org. Accessed 04 Jan 2026"},{"key":"544_CR14","unstructured":"ClinGen CGCNV, Pathogenicity Calculator (2026) https:\/\/cnvcalc.clinicalgenome.org\/redmine\/projects\/cnvcalc\/cnv_calculator\/selector. Accessed 04 Jan 2026"},{"key":"544_CR15","unstructured":"National Library of Medicine, PubMed (2026) https:\/\/pubmed.ncbi.nlm.nih.gov\/. Accessed 04 Jan 2026"},{"key":"544_CR16","unstructured":"LitVar2, National Center for Biotechnology Information (NCBI) (2026) https:\/\/www.ncbi.nlm.nih.gov\/research\/litvar2\/. Accessed 04 Jan 2026"},{"key":"544_CR17","unstructured":"REVEL: Rare Exome Variant Ensemble Learner (2026) https:\/\/sites.google.com\/site\/revelgenomics\/. Accessed 04 Jan 2026"},{"key":"544_CR18","unstructured":"BayesDel, Feng Lab - University of Utah (2026), https:\/\/fenglab.chpc.utah.edu\/BayesDel.html. Accessed 04 Jan 2026"},{"key":"544_CR19","unstructured":"Align GVGD, Huntsman Cancer Institute - University of Utah (2026), agvgd.hci.utah.edu. Accessed 04 Jan 2026"},{"key":"544_CR20","doi-asserted-by":"publisher","unstructured":"Castillo-Guardiola V, Rosado-Jim\u00e9nez L, Sarabia-Meseguer MD, Mar\u00edn-Vera M, Mac\u00edas-Cerrolaza JA, Garc\u00eda-Hern\u00e1ndez R, Zafra-Poves M, S\u00e1nchez-Henarejos P, Moreno-Locubiche M\u00c1, Cuevas-Tortosa E, Arnaldos-Carrillo M, de la Pe\u00f1a F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F (2022) Next step in molecular genetics of hereditary breast\/ovarian cancer: multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance. Eur J Med Genet 65:104468. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104468","DOI":"10.1016\/j.ejmg.2022.104468"},{"key":"544_CR21","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/humu.24088","volume":"41","author":"SV Tavtigian","year":"2020","unstructured":"Tavtigian SV, Harrison SM, Boucher KM, Biesecker LG (2020) Fitting a naturally scaled point system to the ACMG\/AMP variant classification guidelines. Hum Mutat 41:1734\u20131737. https:\/\/doi.org\/10.1002\/humu.24088","journal-title":"Hum Mutat"},{"key":"544_CR22","unstructured":"ClinGen Hereditary Breast, Ovarian and Pancreatic Cancer Expert Panel Specifications to the ACMG\/AMP Variant Interpretation Guidelines for ATM Version 1.1 - ClinGen | Clinical Genome Resource, (n.d.). https:\/\/clinicalgenome.org\/docs\/clingen-hereditary-breast-ovarian-and-pancreatic-cancer-expert-panel-specifications-to-the-acmg-amp-variant-interpretation-1.1\/. Accessed 16 Jan 2023"},{"key":"544_CR23","doi-asserted-by":"publisher","first-page":"iii42","DOI":"10.1093\/annonc\/mdz098.012","volume":"30","author":"B Adamo","year":"2019","unstructured":"Adamo B, Moreno L, Gaba L, Vidal M, Pascual T, Chic N, Alonso I, Puig-Butill\u00e9 JA, Mu\u00f1oz M, Prat A (2019) Multi-gene panel testing at the hereditary breast and ovarian cancer (HBOC) unit of the Hospital Clinic of Barcelona. Ann Oncol 30:iii42\u2013iii43. https:\/\/doi.org\/10.1093\/annonc\/mdz098.012","journal-title":"Ann Oncol"},{"key":"544_CR24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00438-022-01891-5","volume":"297","author":"M Molina-Zayas","year":"2022","unstructured":"Molina-Zayas M, Garrido-Navas C, Garc\u00eda-Puche JL, Barwell J, Pedrinaci S, Atienza MM, Garc\u00eda-Linares S, de Haro-Mu\u00f1oz T, Lorente JA, Serrano MJ, Poyatos-And\u00fajar A (2022) Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective. Mol Genet Genomics 297:859\u2013871. https:\/\/doi.org\/10.1007\/s00438-022-01891-5","journal-title":"Mol Genet Genomics"},{"key":"544_CR25","doi-asserted-by":"publisher","unstructured":"Selection of Germline Genetic Testing Panels in Patients With Cancer (2026) ASCO Guideline | Journal of Clinical Oncology, (n.d.). https:\/\/ascopubs.org\/doi\/https:\/\/doi.org\/10.1200\/JCO.24.00662","DOI":"10.1200\/JCO.24.00662"},{"key":"544_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10549-015-3429-9","volume":"152","author":"C Schroeder","year":"2015","unstructured":"Schroeder C, Faust U, Sturm M, Hackmann K, Grundmann K, Harmuth F, Bosse K, Kehrer M, Benkert T, Klink B, Mackenroth L, Betcheva-Krajcir E, Wimberger P, Kast K, Heilig M, Nguyen HP, Riess O, Schr\u00f6ck E, Bauer P, Rump A (2015) HBOC multi-gene panel testing: comparison of two sequencing centers. Breast Cancer Res Treat 152:129\u2013136. https:\/\/doi.org\/10.1007\/s10549-015-3429-9","journal-title":"Breast Cancer Res Treat"},{"key":"544_CR27","doi-asserted-by":"publisher","unstructured":"Kurian AW, Hughes E, Handorf EA, Gutin A, Allen B, Hartman A-R, Hall MJ (2017) Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.16.00066","DOI":"10.1200\/PO.16.00066"},{"key":"544_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10549-016-4058-7","volume":"161","author":"A Tavera-Tapia","year":"2017","unstructured":"Tavera-Tapia A, P\u00e9rez-Cabornero L, Mac\u00edas JA, Ceballos MI, Roncador G, de la Hoya M, Barroso A, Felipe-Ponce V, Serrano-Blanch R, Hinojo C, Miramar-Gallart MD, Urioste M, Cald\u00e9s T, Santillan-Garz\u00f3n S, Benitez J, Osorio A (2017) Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene. Breast Cancer Res Treat 161:597\u2013604. https:\/\/doi.org\/10.1007\/s10549-016-4058-7","journal-title":"Breast Cancer Res Treat"},{"key":"544_CR29","doi-asserted-by":"publisher","unstructured":"Rosado-Jim\u00e9nez L, Mestre-Terkemani Y, Garc\u00eda-Aliaga \u00c1, Mar\u00edn-Vera M, Mac\u00edas-Cerrolaza JA, Sarabia-Meseguer MD, Garc\u00eda-Hern\u00e1ndez MR, Zafra-Poves M, S\u00e1nchez-Henarejos P, Ayala de la Pe\u00f1a F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F (n.d.) Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia. Adv Lab Med 4:279\u2013287. https:\/\/doi.org\/10.1515\/almed-2023-0103","DOI":"10.1515\/almed-2023-0103"},{"key":"544_CR30","doi-asserted-by":"publisher","first-page":"e67538","DOI":"10.1371\/journal.pone.0067538","volume":"8","author":"A Blanco","year":"2013","unstructured":"Blanco A, de la Hoya M, Osorio A, Diez O, Miramar MD, Infante M, Martinez-Bouzas C, Torres A, Lasa A, Llort G, Brunet J, Gra\u00f1a B, Perez Segura P, Garcia MJ, Guti\u00e9rrez-Enr\u00edquez S, Carracedo \u00c1, Tejada M-I, Velasco EA, Calvo M-T, Balma\u00f1a J, Benitez J, Cald\u00e9s T, Vega A (2013) Analysis of PALB2 gene in BRCA1\/BRCA2 negative Spanish hereditary breast\/ovarian cancer families with pancreatic cancer cases. PLoS ONE 8:e67538. https:\/\/doi.org\/10.1371\/journal.pone.0067538","journal-title":"PLoS ONE"},{"key":"544_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/cas.14242","volume":"111","author":"D Shao","year":"2020","unstructured":"Shao D, Cheng S, Guo F, Zhu C, Yuan Y, Hu K, Wang Z, Meng X, Jin X, Xiong Y, Chai X, Li H, Zhang Y, Zhang H, Liu J, Ye M (2020) Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals. Cancer Sci 111:647\u2013657. https:\/\/doi.org\/10.1111\/cas.14242","journal-title":"Cancer Sci"},{"key":"544_CR32","doi-asserted-by":"publisher","first-page":"e0185615","DOI":"10.1371\/journal.pone.0185615","volume":"12","author":"P-L Sung","year":"2017","unstructured":"Sung P-L, Wen K-C, Chen Y-J, Chao T-C, Tsai Y-F, Tseng L-M, Qiu J-TT, Chao K-C, Wu H-H, Chuang C-M, Wang P-H, Huang C-YF (2017) The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: from BRCA1\/2 to multi-gene panels. PLoS ONE 12:e0185615. https:\/\/doi.org\/10.1371\/journal.pone.0185615","journal-title":"PLoS ONE"},{"key":"544_CR33","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1038\/s41598-022-06376-4","volume":"12","author":"T Andoni","year":"2022","unstructured":"Andoni T, Wiggins J, Robinson R, Charlton R, Sandberg M, Eeles R (2022) Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria. Sci Rep 12:2507. https:\/\/doi.org\/10.1038\/s41598-022-06376-4","journal-title":"Sci Rep"},{"key":"544_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","volume":"7","author":"NJ Samadder","year":"2021","unstructured":"Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, Kunze KL, Golafshar M, Uson Jr PLS, Mountjoy L, Ertz-Archambault N, Patel N, Rodriguez EA, Lizaola-Mayo B, Lehrer M, Thorpe CS, Yu NY, Esplin ED, Nussbaum RL, Sharp RR, Azevedo C, Klint M, Hager M, Macklin-Mantia S, Bryce AH, Bekaii-Saab TS, Sekulic A, Stewart AK (2021) Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol 7:230\u2013237. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6252","journal-title":"JAMA Oncol"},{"key":"544_CR35","unstructured":"British Society for Genetic Medicine (BSGM), Guidance on Incidental Findings (2026) https:\/\/bsgm.org.uk\/healthcare-professionals\/guidance-on-incidental-findings\/. Accessed 04 Jan 2026"},{"key":"544_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","volume":"124","author":"DM van der Kolk","year":"2010","unstructured":"van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJE, de Vries J, van der Hout AH, Oosterwijk JC (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124:643\u2013651. https:\/\/doi.org\/10.1007\/s10549-010-0805-3","journal-title":"Breast Cancer Res Treat"},{"key":"544_CR37","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF (2017) Antoniou, and the BRCA1 and BRCA2 Cohort Consortium, Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA 317:2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"544_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/genes12050616","volume":"12","author":"A Toss","year":"2021","unstructured":"Toss A, Tenedini E, Piombino C, Venturelli M, Marchi I, Gasparini E, Barbieri E, Razzaboni E, Domati F, Caggia F, Grandi G, Combi F, Tazzioli G, Dominici M, Tagliafico E, Cortesi L (2021) Clinicopathologic profile of breast cancer in germline ATM and CHEK2 Mutation Carriers. Genes 12:616. https:\/\/doi.org\/10.3390\/genes12050616","journal-title":"Genes"},{"key":"544_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10689-017-9985-x","volume":"16","author":"MD Gabald\u00f3 Barrios","year":"2017","unstructured":"Gabald\u00f3 Barrios MD, Sarabia Meseguer M, Mar\u00edn Vera M, S\u00e1nchez Berm\u00fadez AI, Mac\u00edas Cerrolaza JA, S\u00e1nchez Henarejos P, Zafra Poves M, Garc\u00eda Hern\u00e1ndez MR, Cuevas Tortosa E, Aliaga Ba\u00f1o \u00c1, Castillo Guardiola V, Mart\u00ednez Hern\u00e1ndez P, Tovar Zapata I, Mart\u00ednez Barba E, Ayala de la Pe\u00f1a F, Alonso Romero JL, Noguera Velasco JA, Ruiz Espejo F (2017) Molecular characterization and clinical interpretation of BRCA1\/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical\u2013pathological features in BRCA carriers and non-carriers. Fam Cancer 16:477\u2013489. https:\/\/doi.org\/10.1007\/s10689-017-9985-x","journal-title":"Fam Cancer"},{"key":"544_CR40","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1158\/1055-9965.EPI-05-0070","volume":"14","author":"JN Weitzel","year":"2005","unstructured":"Weitzel JN, Robson M, Pasini B, Manoukian S, Stoppa-Lyonnet D, Lynch HT, McLennan J, Foulkes WD, Wagner T, Tung N, Ghadirian P, Olopade O, Isaacs C, Kim-Sing C, M\u00f8ller P, Neuhausen SL, Metcalfe K, Sun P, Narod SA (2005) A comparison of bilateral breast cancers in BRCA carriers, cancer epidemiol. Biomarkers Prev 14:1534\u20131538. https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0070","journal-title":"Biomarkers Prev"},{"key":"544_CR41","doi-asserted-by":"publisher","unstructured":"Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou P, Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Borg A, Buys SS, Caldes T, Carter J, Chiquette J, Claes KBM, Couch FJ, Cybulski C, Daly MB, de la Hoya M, Diez O, Domchek SM, Nathanson KL, Durda K, Ellis S, Evans DG, Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Glendon G, Godwin AK, Greene MH, Gronwald J, Hahnen E, Hallberg E, Hamann U, Hansen TVO, Imyanitov EN, Isaacs C, Jakubowska A, Janavicius R, Jaworska-Bieniek K, John EM, Karlan BY, Kaufman B, Kc. investigators, Kwong A, Laitman Y, Lasset C, Lazaro C, Lester J, Loman N, Lubinski J, Manoukian S, Mitchell G, Montagna M, Neuhausen SL, Nevanlinna H, Niederacher D, Nussbaum RL, Offit K, Olah E, Olopade OI, Park SK, Piedmonte M, Radice P, Rappaport-Fuerhauser C, Rookus MA, Seynaeve C, Simard J, Singer CF, Soucy P, Southey M, Stoppa-Lyonnet D, Sukiennicki G, Szabo CI, Tancredi M, Teixeira MR, Teo S-H, Terry MB, Thomassen M, Tihomirova L, Tischkowitz M, Toland AE, Toloczko-Grabarek A, Tung N, van Rensburg EJ, Villano D, Wang-Gohrke S, Wappenschmidt B, Weitzel JN, Zidan J, Zorn KK, McGuffog L, Easton D, Chenevix-Trench G, Antoniou AC, Ramus SJ (2016) EMBRACE, HEBON, Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res. 18:112. https:\/\/doi.org\/10.1186\/s13058-016-0768-3","DOI":"10.1186\/s13058-016-0768-3"},{"key":"544_CR42","doi-asserted-by":"publisher","unstructured":"Mampel A, Sottile ML, Denita-Ju\u00e1rez SP, Vargas AL, Vargas-Roig LM (2022) Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer. Cancer Genet. https:\/\/doi.org\/10.1016\/j.cancergen.2021.11.003","DOI":"10.1016\/j.cancergen.2021.11.003"},{"key":"544_CR43","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3390\/genes13101692","volume":"13","author":"G D\u2019Elia","year":"2022","unstructured":"D\u2019Elia G, Caliendo G, Tzioni M-M, Albanese L, Passariello L, Molinari AM, Vietri MT (2022) Increased risk of hereditary prostate cancer in Italian families with hereditary breast and ovarian cancer syndrome harboring mutations in BRCA and in other susceptibility genes. Genes 13:1692. https:\/\/doi.org\/10.3390\/genes13101692","journal-title":"Genes"},{"key":"544_CR44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12282-012-0432-4","volume":"22","author":"T Nomizu","year":"2015","unstructured":"Nomizu T, Matsuzaki M, Katagata N, Kobayashi Y, Sakuma T, Monma T, Saito M, Watanabe F, Midorikawa S, Yamaguchi Y (2015) A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes. Breast Cancer 22:557\u2013561. https:\/\/doi.org\/10.1007\/s12282-012-0432-4","journal-title":"Breast Cancer"},{"key":"544_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/ijms19010285","volume":"19","author":"R Palmirotta","year":"2018","unstructured":"Palmirotta R, Lovero D, Stucci LS, Silvestris E, Quaresmini D, Cardascia A, Silvestris F (2018) Double heterozygosity for BRCA1 pathogenic variant and BRCA2 polymorphic stop codon K3326X: a case report in a Southern Italian Family. Int J Mol Sci 19:285. https:\/\/doi.org\/10.3390\/ijms19010285","journal-title":"Int J Mol Sci"},{"key":"544_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/jpm11060548","volume":"11","author":"M Fonfria","year":"2021","unstructured":"Fonfria M, de Juan Jim\u00e9nez I, Tena I, Chirivella I, Richart-Aznar P, Segura A, S\u00e1nchez-Heras AB, Martinez-Due\u00f1as (2021) Prevalence and clinicopathological characteristics of moderate and high-penetrance genes in Non-BRCA1\/2 breast cancer high-risk Spanish Families. J Pers Med 11:548. https:\/\/doi.org\/10.3390\/jpm11060548","journal-title":"J Pers Med"},{"key":"544_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13058-018-1011-1","volume":"20","author":"J Penkert","year":"2018","unstructured":"Penkert J, Schmidt G, Hofmann W, Schubert S, Schieck M, Auber B, Ripperger T, Hackmann K, Sturm M, Prokisch H, Hille-Betz U, Mark D, Illig T, Schlegelberger B, Steinemann D (2018) Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Breast Cancer Res 20:87. https:\/\/doi.org\/10.1186\/s13058-018-1011-1","journal-title":"Breast Cancer Res"},{"key":"544_CR48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-014-2971-1","volume":"145","author":"AP Sokolenko","year":"2014","unstructured":"Sokolenko AP, Bogdanova N, Kluzniak W, Preobrazhenskaya EV, Kuligina ES, Iyevleva AG, Aleksakhina SN, Mitiushkina NV, Gorodnova TV, Bessonov AA, Togo AV, Lubi\u0144ski J, Cybulski C, Jakubowska A, D\u00f6rk T, Imyanitov EN (2014) Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN\/NBS1, and BLM germ-line mutations. Breast Cancer Res Treat 145:553\u2013562. https:\/\/doi.org\/10.1007\/s10549-014-2971-1","journal-title":"Breast Cancer Res Treat"},{"key":"544_CR49","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2018.13152","volume":"320","author":"J Mersch","year":"2018","unstructured":"Mersch J, Brown N, Pirzadeh-Miller S, Mundt E, Cox HC, Brown K, Aston M, Esterling L, Manley S, Ross T (2018) Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA 320:1266\u20131274. https:\/\/doi.org\/10.1001\/jama.2018.13152","journal-title":"JAMA"},{"key":"544_CR50","doi-asserted-by":"publisher","unstructured":"Singer C.F., Balma\u00f1a J., B\u00fcrki N., Delaloge S., Filieri M.E., Gerdes A.-M., Grindedal E.M., Han S., Johansson O., Kaufman B., Krajc M., Loman N., Olah E., Paluch-Shimon S., Plavetic N.D., Pohlodek K., Rhiem K., Teixeira M., Evans D.G. (2019) Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations. Eur J Cancer Oxf Engl 1990 106:54\u201360. https:\/\/doi.org\/10.1016\/j.ejca.2018.10.007","DOI":"10.1016\/j.ejca.2018.10.007"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00544-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00544-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00544-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:02:56Z","timestamp":1774292576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00544-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00544-5","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"31"}}